XML 50 R12.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stock Options
9 Months Ended
Sep. 30, 2014
Stock Options

d. Stock Options. Under stockholder approved stock-based plans, stock options, stock appreciation rights, restricted stock and restricted stock units may be granted to officers, directors and other key employees. At September 30, 2014, 2.6 million shares of unissued common stock of the company were available for granting under these plans.

The fair value of stock option awards was estimated using the Black-Scholes option pricing model with the following assumptions and weighted-average fair values:

 

     Nine Months
Ended Sept. 30
 
     2014     2013  

Weighted-average fair value of grant

   $ 11.27      $ 8.76   

Risk-free interest rate

     1.04     .54

Expected volatility

     45.65     50.19

Expected life of options in years

     3.71        3.69   

Expected dividend yield

     —          —     

Restricted stock unit awards may contain time-based units, performance-based units or a combination of both. Each performance-based unit will vest into zero to 1.5 shares depending on the degree to which the performance goals are met. Compensation expense resulting from these awards is recognized as expense ratably for each installment from the date of grant until the date the restrictions lapse and is based on the fair market value at the date of grant and the probability of achievement of the specific performance-related goals.

 

The company records all share-based expense in selling, general and administrative expense.

During the nine months ended September 30, 2014 and 2013, the company recorded $10.6 million and $10.8 million of share-based compensation expense, respectively, which is comprised of $4.2 million and $2.7 million of restricted stock unit expense and $6.4 million and $8.1 million of stock option expense, respectively.

A summary of stock option activity for the nine months ended September 30, 2014 follows (shares in thousands):

 

Options

   Shares     Weighted-
Average
Exercise
Price
     Weighted-
Average
Remaining
Contractual
Term (years)
     Aggregate
Intrinsic
Value
($ in millions)
 

Outstanding at December 31, 2013

     2,698      $ 32.74         

Granted

     749        32.26         

Exercised

     (265     14.06         

Forfeited and expired

     (340     72.90         
  

 

 

         

Outstanding at Sept. 30, 2014

     2,842        29.55         2.62       $ 2.2   
  

 

 

         

Expected to vest at Sept. 30, 2014

     1,346        27.38         3.74         .9   
  

 

 

         

Exercisable at Sept. 30, 2014

     1,463        31.56         1.55         1.3   
  

 

 

         

The aggregate intrinsic value represents the total pretax value of the difference between the company’s closing stock price on the last trading day of the period and the exercise price of the options, multiplied by the number of in-the-money stock options that would have been received by the option holders had all option holders exercised their options on September 30, 2014. The intrinsic value of the company’s stock options changes based on the closing price of the company’s stock. The total intrinsic value of options exercised for the nine months ended September 30, 2014 and 2013 was $4.6 million and $5.7 million, respectively. As of September 30, 2014, $4.0 million of total unrecognized compensation cost related to stock options is expected to be recognized over a weighted-average period of 2.0 years.

A summary of restricted stock unit activity for the nine months ended September 30, 2014 follows (shares in thousands):

 

     Restricted
Stock
Units
    Weighted-
Average
Grant-Date
Fair Value
 

Outstanding at December 31, 2013

     401      $ 23.45   

Granted

     395        32.19   

Vested

     (101     26.85   

Forfeited and expired

     (219     24.77   
  

 

 

   

Outstanding at Sept. 30, 2014

     476        29.36   
  

 

 

   

The fair value of restricted stock units is determined based on the trading price of the company’s common shares on the date of grant. The aggregate weighted-average grant-date fair value of restricted stock units granted during the nine months ended September 30, 2014 and 2013 was $12.7 million and $5.0 million, respectively. As of September 30, 2014, there was $8.9 million of total unrecognized compensation cost related to outstanding restricted stock units granted under the company’s plans. That cost is expected to be recognized over a weighted-average period of 2.3 years. The aggregate weighted-average grant-date fair value of restricted stock units vested during the nine months ended September 30, 2014 and 2013 was $2.7 million and $4.3 million, respectively.

 

Common stock issued upon exercise of stock options or upon lapse of restrictions on restricted stock units is newly issued shares. Cash received from the exercise of stock options for the nine months ended September 30, 2014 and 2013 was $3.3 million and $4.5 million, respectively. In light of its tax position, the company is currently not recognizing any tax benefits from the exercise of stock options or upon issuance of stock upon lapse of restrictions on restricted stock units. Tax benefits resulting from tax deductions in excess of the compensation costs recognized are classified as financing cash flows.